PANews, June 20, reported by PR Newswire, that Parataxis Holdings, a startup focused on Bitcoin investments, has announced it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion KRW (approximately 18.29 million USD), allowing Parataxis Holdings to acquire a controlling stake in the company. Following the completion of this transaction, the company intends to change its name to Parataxis Korea and continue to be listed on the KOSDAQ in South Korea. This transaction will create a Bitcoin-based native fund management platform in the South Korean public market, supported by institutional investors with rich experience in digital asset investments.
Previously reported, Parataxis